Showing 1–24 of 148 trials
National Cancer Institute (NCI)
Why this is shown: Actively enrolling · PHASE2 · 1 site in MD
Merck Sharp & Dohme LLC
Why this is shown: Actively enrolling · PHASE3 · 1 site in FL
Qurgen Inc.
Why this is shown: Actively enrolling · PHASE1 · 5 sites in AZ, MI, NC +2
Context Therapeutics Inc.
Why this is shown: Actively enrolling · PHASE1 · 13 sites in AR, CA, CO +10
Terremoto Biosciences Inc.
Why this is shown: Actively enrolling · Phase 1/2 · 14 sites in FL, MA, MN +9
Memorial Sloan Kettering Cancer Center
Why this is shown: Actively enrolling · 7 sites in NJ, NY
Memorial Sloan Kettering Cancer Center
Why this is shown: Actively enrolling · 7 sites in NJ, NY
Artios Pharma Ltd
Why this is shown: Actively enrolling · Phase 1/2 · 40 sites in AL, AR, AZ +18
Cybrexa Therapeutics
Why this is shown: Actively enrolling · PHASE2 · 17 sites in AZ, CA, CT +10
Clasp Therapeutics, Inc.
Why this is shown: Actively enrolling · PHASE1 · 21 sites in AZ, CA, FL +10
Memorial Sloan Kettering Cancer Center
Why this is shown: Actively enrolling · PHASE2 · 8 sites in MA, NJ, NY
MacroGenics
Why this is shown: Actively enrolling · PHASE2 · 7 sites in CA, LA, MI +3
858 Therapeutics, Inc.
Why this is shown: Actively enrolling · Phase 1/2 · 14 sites in AZ, CT, FL +10
BeiGene
Why this is shown: Actively enrolling · PHASE1 · 6 sites in CA, FL, MO +3
Regeneron Pharmaceuticals
Why this is shown: Actively enrolling · Phase 1/2 · 13 sites in CA, FL, IL +6
NiKang Therapeutics, Inc.
Why this is shown: Actively enrolling · PHASE1 · 19 sites in AR, CA, CO +10
National Cancer Institute (NCI)
Why this is shown: Actively enrolling · Phase 1/2 · 1 site in MD
National Cancer Institute (NCI)
Why this is shown: Actively enrolling · PHASE2 · 1 site in MD
UNC Lineberger Comprehensive Cancer Center
Why this is shown: Actively enrolling · PHASE1 · 1 site in NC
Context Therapeutics Inc.
Why this is shown: Actively enrolling · PHASE1 · 7 sites in CO, IL, MI +4
Loyola University
Why this is shown: Actively enrolling · PHASE2 · 1 site in IL
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Why this is shown: Actively enrolling · PHASE1 · 2 sites in TX, UT
Genelux Corporation
Why this is shown: Actively enrolling · PHASE3 · 31 sites in AL, AZ, CA +16
Case Comprehensive Cancer Center
Why this is shown: Actively enrolling · 1 site in OH